EC strips drug safety measures from patient info proposal to meet 2012 deadline
This article was originally published in Scrip
Executive Summary
The European Commission has backtracked on plans to incorporate some new drug safety measures into the draft legislation on information to patients, in an effort to make sure that the measures are approved in time for the implementation of the new pharmacovigilance rules in mid-2012.